Clinical trials
Phase 2 Neoplasms trials in Greece
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
25 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2003 | 1 |
| 2005 | 2 |
| 2006 | 2 |
| 2007 | 1 |
| 2008 | 3 |
| 2009 | 1 |
| 2012 | 2 |
| 2013 | 1 |
| 2015 | 1 |
| 2017 | 1 |
| 2018 | 2 |
| 2019 | 1 |
| 2021 | 2 |
| 2022 | 2 |
| 2025 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 11 |
| Recruiting | 4 |
| Active, not recruiting | 3 |
| Terminated | 3 |
| Unknown status | 3 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hellenic Oncology Research Group | 7 |
| Novartis Pharmaceuticals | 3 |
| Christian Buske | 2 |
| Hellenic Society of Hematology | 2 |
| Merck Sharp & Dohme LLC | 2 |
| AbbVie | 1 |
| Associació per a la Recerca Oncologica, Spain | 1 |
| BioAtla, Inc. | 1 |
| Bristol-Myers Squibb | 1 |
| Celgene | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Neoplasms | 25 |
| Carcinoma, Non-Small-Cell Lung | 5 |
| Neoplasm Metastasis | 4 |
| Blood Protein Disorders | 3 |
| Breast Neoplasms | 3 |
| Hematologic Diseases | 3 |
| Multiple Myeloma | 3 |
| Neoplasms, Plasma Cell | 3 |
| Paraproteinemias | 3 |
| Recurrence | 3 |
Trials
Showing 1 to 25 of 25. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.